Evidence map›Paper›PMID 28856518›Full record

ArticleClinical rheumatology2019

Changes of patient-reported outcomes and protein fingerprint biomarkers after exercise therapy for axial spondyloarthritis.

Marketa Husakova, Anne Sofie Siebuhr, Karel Pavelka, Maja Spiritovic, Anne-Christine Bay-Jensen, Andrea Levitova

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Marketa HusakovaInstitute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Na Slupi 4, 128 50, Prague 2, Czech Republic. fojtikova05@gmail.com.
Anne Sofie SiebuhrNordic Bioscience, Biomarkers and Research, Herlev, Denmark.
Karel PavelkaInstitute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Na Slupi 4, 128 50, Prague 2, Czech Republic.
Maja SpiritovicInstitute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Na Slupi 4, 128 50, Prague 2, Czech Republic.
Anne-Christine Bay-JensenNordic Bioscience, Biomarkers and Research, Herlev, Denmark.
Andrea LevitovaFaculty of Physical Education and Sports, Department of Adapted Physical Education and Sport Medicine, Charles University, Prague, Czech Republic.
Charles University · CZNordic Bioscience (Denmark) · DKInstitute of Rheumatology · CZ

Funding

Charles University, Faculty of Physical education and Sport Programme of the institutional support for the development of science at Charles University Progress, No. Q41 Biological aspects of the investigation of human movementCharles University, Faculty of Physical Education and Sports SVV for FTVS 2017 - number 260466Grantová Agentura, Univerzita Karlova GAUK number 214615Ministerstvo Zdravotnictví Ceské Republiky Project for Conceptual Development for the institution of the Ministry of Health Czech Republic - Institute of Rheumatology (number 023728),
6 · The paper itself

Abstract

The objective of this study was to investigate the patient-reported outcomes (PROs) and matrix metalloproteinase (MMP) derived extracellular matrix (ECM) biomarkers in non-radiographic (nr)-axial spondyloarthritis (axSpA) and radiographic (r)-axSpA after exercise intervention. Forty-six axSpA patients with stable disease and treatment underwent 24 weeks long exercise intervention. The clinical and laboratory assessments were performed at baseline and at follow-up. The PROs included evaluation of patient's global disease activity (PGDA), disease activity (DA7), pain (PAIN7) and fatigue during last week and quality of life questionnaires. ELISAs for MMP-degraded collagen type II, C-reactive protein (CRPM) and citrullinated vimentin were used. The data of 23 r-axSpA and 19 nr-axSpA were analysed. The PDGA was similar for nr-axSpA (35.2 ± 18.9) and r-axSpA (33.4 ± 22.3) at baseline, improved significantly after intervention (p < 0.01) and the change of PDGA was almost identical for nr-axSpA (- 10.0 ± 15.4) and r-axSpA (- 9.8 ± 11.9). Evaluations of DA7 and PAIN7 were significantly improved only in nr-axSpA (3.5 ± 2.3 and 34.7 ± 25.6 at baseline vs. 2.1 ± 1.9 and 21.0 ± 20.5, respectively, p < 0.01). The decline of DA7 and PAIN7 was more profound, but not significantly in nr-axSpA than in r-axSpA (- 1.4 ± 1.6 and - 13.7 ± 17.4 vs. - 0.5 ± 3.1 and - 3.7 ± 3.3, respectively). The quality of life was not changed. At baseline, increased levels of CRPM were found in r-axSpA (14.85 ± 4.10) compared to nr-axSpA (11.83 ± 3.20), p < 0.05, but all three biomarkers were not influenced by exercise therapy. We found that exercise therapy mainly in the nr-axSpA improves PROs, but not ECM turnover biomarkers. This indicates that exercise therapy is important for patients' health but does not affect ECM turnover.

Indexed as

Exercise TherapyPatient Reported Outcome MeasuresAdultBiomarkersC-Reactive ProteinFemaleHumansMaleMatrix MetalloproteinasesPeptide MappingQuality of LifeSpondylarthritisBiomarkersC-Reactive ProteinMatrix Metalloproteinasesaxial spondyloarthritisexercise therapyextracellular matrixmatrix metalloproteinase

Identifiers

PMID28856518
OpenAlexW2751335667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.